Fundraising Fox
Foresight Diagnostics
acquired by NateraBoulder, US · Founded 2020 · 113 employees on LinkedIn · 6 known investors
Find your way into Foresight Diagnostics
Sign up to see every warm intro you have to Foresight Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Foresight Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by Natera December 2025 · $424.5M ($424.5M total purchase consideration (all-stock; $275M upfront plus up to $175M earnouts, headline value up to $450M)) · source ↗
Foresight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.
Founders & leadership
Investors · 6
How we know: Agent Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Civilization Ventures Management, Llc's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Foresite Capital's portfolio page · a partner's Signal profile · Not right? Tell us
Founder mafia
2 people who came through Foresight Diagnostics went on to found or lead other companies.
Related companies · 3
Companies working in the same space as Foresight Diagnostics.
Frequently asked questions
- What does Foresight Diagnostics do?
- Foresight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.
- Who are Foresight Diagnostics's investors?
- Foresight Diagnostics's investors include Agent Capital, Boulder Ventures, Civilization Ventures Management, Llc, CU Healthcare Innovation Fund, Foresite Capital, Pear VC.
- Who acquired Foresight Diagnostics?
- Foresight Diagnostics was acquired by Natera.
- Where is Foresight Diagnostics headquartered?
- Foresight Diagnostics is headquartered in Boulder, US.